Search Results

There are 19911 results for: content related to: Infertility: Evaluation and Initial Management

  1. You have free access to this content
    Aromatase inhibitors for subfertile women with polycystic ovary syndrome

    Intervention Review

    The Cochrane Library

    Sebastian Franik, Jan AM Kremer, Willianne LDM Nelen and Cindy Farquhar

    Published Online : 24 FEB 2014, DOI: 10.1002/14651858.CD010287.pub2

  2. Letrozole versus clomiphene citrate for unexplained infertility: A systematic review and meta-analysis

    Journal of Obstetrics and Gynaecology Research

    Volume 40, Issue 5, May 2014, Pages: 1205–1216, Aihai Liu, Chao Zheng, Junzhe Lang and Wenbing Chen

    Version of Record online : 22 APR 2014, DOI: 10.1111/jog.12393

  3. Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 5, November 2011, Pages: 693–700, Z Desta, Y Kreutz, A T Nguyen, L Li, T Skaar, L K Kamdem, N L Henry, D F Hayes, A M Storniolo, V Stearns, E Hoffmann, R F Tyndale and D A Flockhart

    Version of Record online : 5 OCT 2011, DOI: 10.1038/clpt.2011.174

  4. The effect of tamoxifen on the pharmacokinetics of letrozole in female rats

    Biopharmaceutics & Drug Disposition

    Volume 27, Issue 7, October 2006, Pages: 335–344, X. Tao, A. M. H. Brodie and I. P. Nnane

    Version of Record online : 15 AUG 2006, DOI: 10.1002/bdd.514

  5. Aromatase Inhibitors and Breast Cancer

    Annals of the New York Academy of Sciences

    Volume 1155, Issue 1, February 2009, Pages: 162–173, Luciana Furtado Macedo, Gauri Sabnis and Angela Brodie

    Version of Record online : 26 FEB 2009, DOI: 10.1111/j.1749-6632.2008.03689.x

  6. Plasma Protein Binding of Letrozole, a New Nonsteroidal Aromatase Enzyme Inhibitor

    The Journal of Clinical Pharmacology

    Volume 38, Issue 8, August 1998, Pages: 727–735, Danielle M. Colussi, Carole Y. Parisot and Gilbert Y. Lefèvre

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04813.x

  7. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women

    Intervention Review

    The Cochrane Library

    Lorna Gibson, David Lawrence, Claire Dawson and Judith Bliss

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD003370.pub3

  8. You have free access to this content
    Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer


    Volume 75, Issue 8, 15 April 1995, Pages: 2132–2138, Allan Lipton, Laurence M. Demers, Harold A. Harvey, Kathleen B. Kambic, Howard Grossberg, Carolyn Brady, H. Adlercruetz, Patrick F. Trunet and Richard J. Santen

    Version of Record online : 28 JUN 2006, DOI: 10.1002/1097-0142(19950415)75:8<2132::AID-CNCR2820750816>3.0.CO;2-U

  9. You have free access to this content
    A randomized Phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma


    Volume 80, Issue 2, 15 July 1997, Pages: 218–224, James N. Ingle, Patricia A. Johnson, Vera J. Suman, James B. Gerstner, James A. Mailliard, John K. Camoriano, Dean H. Gesme Jr., Charles L. Loprinzi, Alan K. Hatfield and Lynn C. Hartmann

    Version of Record online : 15 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19970715)80:2<218::AID-CNCR8>3.0.CO;2-P

  10. You have free access to this content
    Effect of letrozole on uterine artery Doppler flow indices prior to first-trimester termination of pregnancy: a randomized controlled trial

    Ultrasound in Obstetrics & Gynecology

    Volume 40, Issue 4, October 2012, Pages: 392–397, V. C. Y. Lee, T. W. Y. Yeung, O. S. Tang, E. H. Y. Ng, W. S. B. Yeung and P. C. HO

    Version of Record online : 25 SEP 2012, DOI: 10.1002/uog.11115

  11. You have free access to this content
    Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada

    Value in Health

    Volume 3, Issue 1, January/February 2000, Pages: 31–39, Mark Nuijten, John McCormick, Franz Waibel and Diana Parison

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1524-4733.2000.31004.x

  12. Investigation on the interaction of letrozole with herring sperm DNA through spectroscopic and modeling methods


    Volume 31, Issue 5, August 2016, Pages: 1077–1084, Yan-Mei Huang, Shou-Jun Zheng, Jin Yan, Hong-Qin Yang, Di Wu, Qing Wang and Hui Li

    Version of Record online : 16 DEC 2015, DOI: 10.1002/bio.3074

  13. Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1852–1860, Dr Lauren Nicole Bell, Ms Anne Thi Phuong Nguyen, Dr Lang Li, Dr Zeruesenay Desta, Dr N. Lynn Henry, Dr Daniel F. Hayes, Dr Antonio C. Wolff, Dr Vered Stearns, Dr Anna Maria Storniolo and Dr David A. Flockhart

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011424153

  14. You have full text access to this OnlineOpen article
    Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients

    Cancer Science

    Volume 107, Issue 6, June 2016, Pages: 755–763, Kenji Tamura, Hirofumi Mukai, Yoichi Naito, Kan Yonemori, Makoto Kodaira, Yuko Tanabe, Noboru Yamamoto, Shozo Osera, Masaoki Sasaki, Yuko Mori, Satoshi Hashigaki, Takashi Nagasawa, Yoshiko Umeyama and Takayuki Yoshino

    Version of Record online : 11 MAY 2016, DOI: 10.1111/cas.12932

  15. You have free access to this content
    Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells

    International Journal of Cancer

    Volume 104, Issue 2, 20 March 2003, Pages: 155–160, Theoni N. Mitropoulou, George N. Tzanakakis, Dimitris Kletsas, Haralabos P. Kalofonos and Nikas K. Karamanos

    Version of Record online : 3 JAN 2003, DOI: 10.1002/ijc.10941

  16. Absolute bioavailability of letrozole in healthy postmenopausal women

    Biopharmaceutics & Drug Disposition

    Volume 18, Issue 9, December 1997, Pages: 779–789, A. Sioufi, N. Gauducheau, V. Pineau, F. Marfil, A. Jaouen, J. M. Cardot, J. Godbillon, C. Czendlik, H. Howald, CH. Pfister and F. Vreeland

    Version of Record online : 4 DEC 1998, DOI: 10.1002/(SICI)1099-081X(199712)18:9<779::AID-BDD64>3.0.CO;2-5

  17. When to start an aromatase inhibitor: Now or later?

    Journal of Surgical Oncology

    Volume 103, Issue 7, 1 June 2011, Pages: 730–738, Julie C. Doughty

    Version of Record online : 24 FEB 2011, DOI: 10.1002/jso.21801

  18. You have free access to this content
    Acupuncture does not ameliorate metabolic disturbances in the P450 aromatase inhibitor-induced rat model of polycystic ovary syndrome

    Experimental Physiology

    Volume 102, Issue 1, 1 January 2017, Pages: 113–127, Manuel Maliqueo, Anna Benrick, Rodrigo Rodrigues Marcondes, Julia Johansson, Miao Sun and Elisabet Stener-Victorin

    Version of Record online : 3 JAN 2017, DOI: 10.1113/EP085983

  19. Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozole

    Biopharmaceutics & Drug Disposition

    Volume 31, Issue 2-3, March - April 2010, Pages: 138–149, Li Li, Liang Fang, Xinlan Xu, Yu Liu, Yinghua Sun and Zhonggui He

    Version of Record online : 7 FEB 2010, DOI: 10.1002/bdd.698

  20. Clomiphene and letrozole for reducing FSH consumption during ovarian stimulation: systematic review and meta-analysis

    Ultrasound in Obstetrics & Gynecology

    Accepted manuscript online: 25 FEB 2017, Tatiana N B Marcal, Mariane N Nadai, Carolina O Nastri and Wellington P Martins

    DOI: 10.1002/uog.17442